Top Purchase Related
Home
>
Node
>
Subnode

Drug-induced movement disorders

Powers, J.M.

Arizona Medicine 40(7): 464-467

1983

ISSN/ISBN: 0004-1556
PMID: 6138016
Document Number: 197771

Document emailed within 1 workday
Secure & encrypted payments

Velázquez-Pérez, J.M.; Marsal-Alonso, C. 2009: Drug-induced movement disorders Revista de Neurologia 48(Suppl 1): S57-S60
Butković-Soldo, S.; Tomić, S.; Stimac, D.; Knezević, L.; Palić, R.; Jurić, S.; Marijanović, K. 2005: Patients review: drug-induced movement disorders Collegium Antropologicum 29(2): 579-582
Wolf, M.A.; Yassa, R.; Llorca, P.M. 2002: Neuroleptic-induced movement disorders: historical perspectives L'Encephale 19(6): 657-661
Wolf, M.A.; Yassa, R.; Llorca, P.M. 1993: Neuroleptic-induced movement disorders: historical perspectives L'Encephale 19(6): 657-661
Bolgár, B.; Arany, Ádám.; Temesi, G.; Balogh, Bázs.; Antal, Péter.; Mátyus, Péter. 2013: Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies Current Topics in Medicinal Chemistry 13(18): 2337-2363
Kasantikul, D.; Kanchanatawan, B. 2007: Antipsychotic-induced tardive movement disorders: a series of twelve cases Journal of the Medical Association of Thailand 90(1): 188-194
Herrmann, D. 1976: Significance of hip-involvement in the early diagnosis and treatment of children with cerebrally-induced movement disorders Zeitschrift für Arztliche Fortbildung 70(1): 34-35
Lukomskaia, N.I.; Zhabko, E.P.; Gmiro, V.E. 1999: The participation of glutaminergic transmission in the mechanism of movement disorders induced by reverse rotation in white mice Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 85(4): 497-501
Timberlake, W.H. 1970: Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders Neurology 20(12): 31-35
Farnè, M. 1970: Movement induced in the third dimension. II. Effect of an apparent movement Bollettino della Societa Italiana di Biologia Sperimentale 46(10): 526-528
Kohashi, S.; Okamoto, S. 2012: Drug induced hematological disorders Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 74-77
2014: Drug-induced nail disorders Prescrire International 23(151): 180-182
Danielson, D.A.; Douglas, S.W.; Herzog, P.; Jick, H.; Porter, J.B. 1984: Drug-induced blood disorders JAMA 252(23): 3257-3260
Rutka, J.; Alberti, P.W. 1984: Toxic and drug-induced disorders in otolaryngology Otolaryngologic Clinics of North America 17(4): 761-774
Neundörfer, B. 1973: Drug-induced neurologic and muscular disorders Die Medizinische Welt 24(17): 676-679
Fréneaux, E.; Pessayre, D. 1993: Drug-induced steatosis, phospholipidosis and pseudo-alcoholic liver disorders Gastroenterologie Clinique et Biologique 17(5 Part 2): H36-H43
Zhang, S-yu.; Zhao, H.; Tang, T.; Guan, W. 2014: Assessment on the criminal responsibility of drug-induced mental disorders: a questionnaire survey Fa Yi Xue Za Zhi 30(6): 431-433
Timour, Q.; Freysz, M.; Couzon, P.; Loufoua, J.; Bertrix, L.; Gerentes, I.; Faucon, G. 1990: Possible role of drug interactions in bupivacaine-induced problems related to intraventricular conduction disorders Regional Anesthesia 15(4): 180-185
Yamaji, Y.; Uchida, S.; Miyajima, Y.; Kamane, S.; Ogata, E. 1995: A drug-induced transient Fanconi syndrome associated with pure red cell aplasia: pathophysiology of the electrolyte disorders Nihon Jinzo Gakkai Shi 37(1): 44-48
Vela-Desojo, L.; Vaamonde-Gamo, J.; Obeso-Insausti, J.A. 2000: Paroxysmal movement disorders Revista de Neurologia 31(1): 71-79